Alnylam Pharmaceuticals shares owned by Blackstone Group
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.9M | 8.8k | 330.87 |
| 2022-03-31 | $85M | 517k | 163.29 |
| 2021-12-31 | $88M | 517k | 169.58 |
| 2021-09-30 | $98M | 517k | 188.81 |
| 2021-06-30 | $88M | 517k | 169.52 |
| 2021-03-31 | $90M | 638k | 141.19 |
| 2020-12-31 | $83M | 638k | 129.97 |
| 2020-09-30 | $119M | 816k | 145.60 |
| 2020-06-30 | $137M | 925k | 148.11 |